Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 구혜령 | - |
dc.date.accessioned | 2019-11-30T03:44:24Z | - |
dc.date.available | 2019-11-30T03:44:24Z | - |
dc.date.issued | 2017-08 | - |
dc.identifier.citation | EUROPEAN RADIOLOGY, v. 27, no. 8, page. 3211-3216 | en_US |
dc.identifier.issn | 0938-7994 | - |
dc.identifier.issn | 1432-1084 | - |
dc.identifier.uri | https://link.springer.com/article/10.1007%2Fs00330-016-4721-8 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/115333 | - |
dc.description.abstract | aEuro cent BI-RADS category 3 lesions on preoperative MRI had 0.8% malignancy rate.aEuro cent All cancer diagnoses from BI-RADS 3 occurred after 24-month follow-up.aEuro cent Annual follow-up might be adequate for BI-RADS 3 detected on preoperative MRI. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | SPRINGER | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | Magnetic resonance imaging | en_US |
dc.subject | Follow-up studies | en_US |
dc.subject | Imaging | en_US |
dc.subject | Appointments and schedule | en_US |
dc.title | Management for BI-RADS category 3 lesions detected in preoperative breast MR imaging of breast cancer patients | en_US |
dc.type | Article | en_US |
dc.relation.no | 8 | - |
dc.relation.volume | 27 | - |
dc.identifier.doi | 10.1007/s00330-016-4721-8 | - |
dc.relation.page | 3211-3216 | - |
dc.relation.journal | EUROPEAN RADIOLOGY | - |
dc.contributor.googleauthor | Gweon, Hye Mi | - |
dc.contributor.googleauthor | Cho, Nariya | - |
dc.contributor.googleauthor | Kim, Soo-Yeon | - |
dc.contributor.googleauthor | Koo, Hye Ryoung | - |
dc.contributor.googleauthor | Seo, Mirinae | - |
dc.contributor.googleauthor | Chu, Ajung | - |
dc.contributor.googleauthor | Son, Eun Ju | - |
dc.relation.code | 2017003699 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | huilings | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.